Elnaz Menhaji‐Klotz
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Chemokine receptors and signaling, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Computational Drug Discovery Methods
Most-Cited Works
- → Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor(2017)109 cited
- → Glycomimetic Ligands for the Human Asialoglycoprotein Receptor(2012)105 cited
- → An Enantioselective Total Synthesis and Stereochemical Revision of (+)-Citrinadin B(2013)86 cited
- → Discovery of Potent and Orally Bioavailable Macrocyclic Peptide–Peptoid Hybrid CXCR7 Modulators(2017)70 cited
- → Spirolactam-Based Acetyl-CoA Carboxylase Inhibitors: Toward Improved Metabolic Stability of a Chromanone Lead Structure(2013)47 cited
- → Synthesis of Spiropiperidine Lactam Acetyl-CoA Carboxylase Inhibitors(2012)33 cited
- → 2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity(2011)25 cited
- → Discovery of a Novel Small-Molecule Modulator of C–X–C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis(2018)24 cited
- → Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity(2020)16 cited
- → Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7(2021)4 cited